Anke
Anke Abken, Whitehouse, OH US
Patent application number | Description | Published |
---|---|---|
20100212731 | Photovoltaic Devices Including Controlled Copper Uptake - A photovoltaic cell can include a substrate having a copper-doped semiconductor layer. The doping can be mediated with a salt. | 08-26-2010 |
20100307561 | DOPED METAL CONTACT - A photovoltaic device can include a second metal layer adjacent to a first layer, where the first layer is positioned adjacent to a substrate, and where the second metal layer includes a dopant; and a copper-indium-gallium diselenide (CIGS) layer adjacent to the second metal layer. | 12-09-2010 |
20100307568 | METAL BARRIER-DOPED METAL CONTACT LAYER - A photovoltaic device can include an intrinsic metal layer adjacent to a semiconductor absorber layer; and a doped metal contact layer adjacent to the intrinsic metal layer, where the doped metal contact layer includes a metal base material and a dopant. | 12-09-2010 |
20100326491 | DOPANT-CONTAINING CONTACT MATERIAL - A photovoltaic device can include a doped contact layer adjacent to a semiconductor absorber layer, where the doped contact layer includes a metal base material and a dopant. | 12-30-2010 |
20110136294 | Plasma-Treated Photovoltaic Devices - A method of manufacturing a thin film photovoltaic device includes depositing a first compound semiconductor layer on a substrate and exposing the device to plasma, the plasma treating the layer. | 06-09-2011 |
20130005075 | METAL BARRIER-DOPED METAL CONTACT LAYER - A photovoltaic device can include an intrinsic metal layer adjacent to a semiconductor absorber layer; and a doped metal contact layer adjacent to the intrinsic metal layer, where the doped metal contact layer includes a metal base material and a dopant. | 01-03-2013 |
Anke Abken, Toledo, OH US
Patent application number | Description | Published |
---|---|---|
20090194166 | PHOTOVOLTAIC DEVICES INCLUDING DOPED SEMICONDUCTOR FILMS - A photovoltaic cell can include a dopant in contact with a semiconductor layer. | 08-06-2009 |
20090255578 | Plasma-treated photovoltaic devices - A method of manufacturing a thin film photovoltaic device includes depositing a first compound semiconductor layer on a substrate and exposing the device to plasma, the plasma treating the layer. | 10-15-2009 |
Anke Allwardt, Beckenried CH
Patent application number | Description | Published |
---|---|---|
20100133046 | ELEVATOR SYSTEM, SUSPENSION ELEMENT FOR AN ELEVATOR SYSTEM, AND DEVICE FOR MANUFACTURING A SUSPENSION ELEMENT - An elevator system with a car or platform to transport passengers and/or goods as well as with a counterweight, which are arranged as traversable or movable along a travel path, and which are coupled and/or with a drive by a suspension element interrelating their motion. The suspension element is guided and/or driven by a traction sheave and/or a drive shaft and/or a deflecting pulley. The suspension element is sheathed and/or belt-type, with a first layer made of a first plasticizable and/or elastomeric material, containing a first exterior surface, and with at least one tension member—rope-type, tissue-type, or comprising a multitude of partial elements—that is embedded in the first layer of the suspension element. A manufacturing procedure for one of the suspension elements is provided. | 06-03-2010 |
20150024891 | SUSPENSION ELEMENT FOR AN ELEVATOR SYSTEM - An elevator system includes a car or platform to transport passengers and/or goods as well as a counterweight, which are arranged as traversable or movable along a travel path, and which are coupled and/or with a drive by a suspension element interrelating their motion. The suspension element is guided and/or driven by a traction sheave and/or a drive shaft and/or a deflecting pulley. The suspension element is a sheathed and/or belt-type, with a first layer made of a first plasticizable and/or elastomeric material and a second layer with a connection plane formed between the first and second layers. At least one tension member—rope-type, tissue-type, or comprising a multitude of partial elements—is embedded in an area of the connection plane, a majority of a surface of said at least one tension member directly contacting said first layer. A manufacturing procedure for one of the suspension elements is provided. | 01-22-2015 |
Anke Beselin, Mulheim DE
Patent application number | Description | Published |
---|---|---|
20090104657 | Lipase Production Method - The invention relates to novel proteins, especially with protease activity, which promote the production of extracellular lipases by bacteria, especially of the genus | 04-23-2009 |
Anke Blaul, Darmstadt DE
Patent application number | Description | Published |
---|---|---|
20110088589 | Anticorrosion additives for manufacturing processes, a process for preparation thereof and use thereof - The present invention relates to novel anticorrosion additives for manufacturing processes, comprising at least one triazole and the reaction product of at least one alkylene glycol and at least one carboxylic anhydride, to a process for preparation thereof and to the use thereof for corrosion protection for aluminium and/or aluminium alloys. | 04-21-2011 |
20120071595 | Novel aqueous resorcinol-formaldehyde-latex dispersions, adhesion-improved fibres, processes for production thereof and use thereof - The present invention relates to novel aqueous resorcinol-formaldehyde-latex dispersion, to adhesion-improved fibres, to processes for production thereof, and to use thereof for improving adhesion in tyres. | 03-22-2012 |
20120074358 | Anticorrosion additives for manufacturing processes, a process for preparation thereof and use thereof - The present invention relates to novel anticorrosion additives for manufacturing processes, comprising at least one triazole and the reaction product of at least one alkylene glycol and at least one carboxylic anhydride, to a process for preparation thereof and to the use thereof for corrosion protection for aluminium and/or aluminium alloys. | 03-29-2012 |
20120100290 | Novel bonding agents based on carbodiimides, aqueous resorcinol-formaldehyde-latex dispersions comprising bonding agent, adhesion-improved fibres, processes for production thereof and use thereof - The present invention relates to novel bonding agents based on carbodiimides, to aqueous resorcinol-formaldehyde-latex dispersion comprising bonding agent, to adhesion-improved fibres, to processes for production thereof, and to use thereof for improving adhesion in tyres. | 04-26-2012 |
20120123062 | Process for preparing carbodiimides - A method for producing compounds comprising at least one carbodiimide group is described, by reacting at least one isocyanate-containing starting compound or a derivative thereof, wherein the method is conducted in at least two stages. | 05-17-2012 |
Anke BrÖnstrup, Weesen CH
Patent application number | Description | Published |
---|---|---|
20110284364 | Aluminum Doped Zinc Oxide Sputtering Targets - A sputtering target precursor material comprises a homogeneous distribution of a ZnAl | 11-24-2011 |
Anke Buchholz, Stein CH
Patent application number | Description | Published |
---|---|---|
20100267563 | METHOD OF IMPROVING THE GROWTH OF A PLANT - A method of improving the growth of a plant comprising applying to a plant, plant propagation material or locus thereof a composition comprising a product, which comprises microcapsules which themselves comprise (a) a polymeric shell; and (b) a core which comprises a dispersed solid active ingredient compound wherein the compound is one or more of a neonicotinoid, fipronil, a strobilurin, carboxin, acibenzolar-S-methyl, and probenazole. | 10-21-2010 |
20130150394 | PESTICIDAL COMPOSITIONS - A pesticidal composition comprising a pesticidal effective amount of at least one compound of formula (I) in which the substituents are as defined as in claim | 06-13-2013 |
20130225411 | PESTICIDAL COMPOSITIONS - A pesticidal composition comprising (a) a pesticidal effective amount of at least one compound of formula I in which Q is i or ii or iii or an agrochemically acceptable salt or an N-oxide thereof, and (b) a plant growth regulator, where the ratio of compound of formula I to plant growth regulator is from 20:1 to 1:25. | 08-29-2013 |
20140018242 | METHOD OF CROP ENHANCEMENT - A method of enhancing a crop by applying to the crop or a locus thereof a compound of formula (I) in which Q is i or ii or iii. | 01-16-2014 |
20140336048 | PESTICIDAL MIXTURES INCLUDING SPIROHETEROCYCLIC PYRROLIDINE DIONES - A pesticidal mixture comprising as active ingredient a mixture of component A and component B, wherein component A is a compound of formula (I), in which Q is i or ii wherein X, Y and Z, m and n, A, G, and R, are as defined as in claim | 11-13-2014 |
20150031533 | PESTICIDAL MIXTURES INCLUDING SPIROHETEROCYCLIC PYRROLIDINE DIONES - A pesticidal mixture comprising as active ingredient a mixture of component A and component B, wherein component A is a compound of formula (I), in which Q is i or ii wherein X, Y and Z, m and n, A, G, and R, are as defined as in claim | 01-29-2015 |
Anke Burger-Kentischer, Stuttgart DE
Patent application number | Description | Published |
---|---|---|
20090253134 | Cellular Pyrogen Test - The invention concerns methods, agents and kits for qualitative and quantitative detection and identification of pathogens and pathogen spectra based on endotoxins and other pyrogens. | 10-08-2009 |
20110300530 | IN VITRO TEST SYSTEM FOR VIRAL INFECTIONS - The invention relates to a multi-layered biological in vitro tissue containing: dermis layer, containing a collagen biomatrix with fibroblasts embedded therein and epidermis layer, containing epithelial cells. It is provided that latently virally infected neuronal cells are integrated at least into the dermis layer. | 12-08-2011 |
Anke Domaske, Hannover DE
Patent application number | Description | Published |
---|---|---|
20130256942 | Process for Producing Milk Protein Fibers and Milk Protein Fiber Products Obtained Therefrom - Milk protein fibers are produced by an extrusion process for the textile industry inter alia, in which at least one thermoplasticizable protein obtained from milk is plasticized with a plasticizer, for example water or glycerol, at temperatures between room temperature and 140° C., under mechanical stress and spun to fibers by means of a jet. | 10-03-2013 |
20140373748 | METHOD FOR PRODUCING MILK PROTEIN GELS, -HYDROGELS, -HYDROCOLLOIDES AND -SUPERABSORBERS (MILK PROTEIN GELS) - The disclosure relates to a milk protein hydrol gel, in which at least one protein which is obtained from milk and which can be thermally plasticized, is plasticized using a plasticizing agent, such as for example, water or glycerol at temperatures between room temperature and preferably up to 140° C. by means of mechanical stress and subsequently retreated according to a continuous or discontinuous process to form hydrogels. | 12-25-2014 |
20150013569 | METHOD FOR PRODUCING A MILK PROTEIN BASED PLASTIC MATERIAL (MP BASED PLASTIC MATERIAL) - The disclosure relates to a milk protein based plastic material produced according to a plastic material shaping method, known by a person skilled in the art and the literature, in which at least one protein, which is obtained from milk and which can be thermally plasticized, is plasticized using a plasticizing agent, such as for example water or glycerol at temperatures of between room temperature and 140° C., subjected to mechanical stress and subsequently retreated according to a production method, known to person skilled in the art and literature, to form moulded bodies. | 01-15-2015 |
20150024430 | METHOD FOR PRODUCING MILK PROTEIN NANOPARTICLES - The disclosure relates to milk protein nanoparticles produced according to a polymerization method in which at least one protein, which is obtained from milk and which can be thermally plasticized, is plasticized using a plasticizing agent, such as for example, water or glycerol at temperatures between room temperature and 140° C., subjected to mechanical stress and subsequently retreated, for example, in the top down or bottom up method to form nanoparticles. | 01-22-2015 |
Anke Esperester, Mainz DE
Patent application number | Description | Published |
---|---|---|
20080319087 | Use of Ambroxol for the Treatment of Rhinovirus Infections - The invention is directed to the use of ambroxol or pharmaceutically acceptable salts thereof for preparing a medical composition for treating or preventing infections caused by human rhinovirus. Surprisingly it was found that Ambroxol is capable to suppress the replication of human rhinovirus. Therefore, the ambroxol-containing medical composition is suitable to treat or prevent against all symptoms of a rhinovirus infection and provides a direct antivirale effect. | 12-25-2008 |
20100330176 | Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity - The invention relates to the use of ambroxol and the pharmacologically acceptable salts thereof for preparing a pharmaceutical composition for the treatment of painful conditions in the oral and pharyngeal cavity. | 12-30-2010 |
20110053874 | USE OF FLAVONOIDE COMPOUNDS FOR THE PROPHYLAXIS AND THERAPY OF ISCHAEMIC OR INFLAMMATORY HEART AND CARDIOVASCULAR DISEASES - The present invention relates to the use of flavonoid compounds, particularly quercetin-3-O-β-D-glucuronide and kaempferol-3-O-β-D-glucuronide and their glucosides, for preventing diseases of the heart. Red vine leaf extract has proved a particularly advantageous source of the flavonoid compounds in question. | 03-03-2011 |
20110129809 | METHODS FOR THE ANTI-INFLAMMATORY AND ANTI-EDEMATOUS PROTECTION OF EXPLANTED BIOLOGICAL MATERIAL UNTIL THE TRANSPLANTATION THEREOF IN PATIENTS - The invention relates to a method for protecting transplants, as well as organs and individual blood vessels, against inflammatory reactions that are caused by the operative procedure linked to the explantation and storage until transplantation. This can be achieved by treating the transplant via intra arterial application of flavonol compounds, in particular with quercetin glucuronide and/or kaempferol glucuronide. | 06-02-2011 |
Anke Frahn, Granville, OH US
Patent application number | Description | Published |
---|---|---|
20130098501 | PACKAGING SYSTEM FOR PHARMACEUTICAL DISPENSER AND ASSOCIATED METHOD - A packaging system and associated method for use with a pharmaceutical dispenser provides a turnkey solution for packaging pharmaceutical products such as solid medications and nutritional supplements to be taken orally in health care settings, including but not limited to long term care (LTC) and assisted living settings. An overall pharmacy system and methodology begins with bulk medications and supplements introduced into the work flow, individually packaged and assembled into medpass orders per patient and delivered to the LTC facility or other institution for patient consumption. The process begins by converting bulk medications and supplements to packaged unit doses and ultimately individually packaged medpass bags for each patient on a 24-hour schedule. The design of the overall system and its individual components allows for physical control of each unit dose package from start to finish without any unit dose package “free fall” in the system. | 04-25-2013 |
20130101377 | PACKAGING SYSTEM FOR PHARMACEUTICAL DISPENSER AND ASSOCIATED METHOD - A packaging system and associated method for use with a pharmaceutical dispenser provides a turnkey solution for packaging pharmaceutical products such as solid medications and nutritional supplements to be taken orally in health care settings, including but not limited to long term care (LTC) and assisted living settings. An overall pharmacy system and methodology begins with bulk medications and supplements introduced into the work flow, individually packaged and assembled into medpass orders per patient and delivered to the LTC facility or other institution for patient consumption. The process begins by converting bulk medications and supplements to packaged unit doses and ultimately individually packaged medpass bags for each patient on a 24-hour schedule. The design of the overall system and its individual components allows for physical control of each unit dose package from start to finish without any unit dose package “free fall” in the system. | 04-25-2013 |
Anke Frohberger, Heidelberg DE
Patent application number | Description | Published |
---|---|---|
20100017032 | DEVICE FOR CONTROLLING A ROBOT - A device is disclosed for controlling a robot, with a robot control unit, and with a robot sensor such as a digital camera, which can be fitted on the robot and whose output signals can be supplied to an image recording unit. The output signals from the image recording unit connected to the camera can be supplied to an image processing device which is connected to the image recording unit. A coordinate transformation device is provided, in which the signals originating from the image processing unit and the robot control unit are processed and transformed into robot control signals, and the signals can be supplied back to the robot control unit. | 01-21-2010 |
20140123104 | METHOD AND DEVICE FOR THE PROGRAMMING AND CONFIGURATION OF A PROGRAMMABLE LOGIC CONTROLLER - A method and device for the programming and configuration of a programmable logic controller are disclosed. The method can include: locating a configuration tool in a programming tool, wherein the configuration tool includes a module in an IEC61131 language; integrating at least one further module into the configuration tool, and executing the programming and configuration of the programmable logic controller in a high-level language using a C-Code editor, and wherein the at least one further module is configured to provide a definition of interfaces between an IEC61131 code and a high-level language code, and provide a configuration of the high-level language code. | 05-01-2014 |
Anke Hasenkox, Viersen DE
Patent application number | Description | Published |
---|---|---|
20120024135 | MORTAR - A mortar includes at least one barrel mounted movably over a ball journal in a bottom supporting device, and an aiming device serving to aim the barrel vertically and horizontally. In order to be able to aim the barrel of the mortar automatically in a simple and cost advantageous manner, the aiming device preferably comprises a carriage that can be moved along guideways essentially horizontally towards or away from the barrel. At the carriage, the first end region of a pivoted arm is mounted so that it can be rotated about a pivot axis, and the second end region of the pivoted arm is connected with a spherical plain bearing, guiding the barrel. The spherical plain bearing embraces a housing part, which is open at its end faces and in which an inner part is mounted spherically (rotatably), which contains a cylindrical barrel guide, for movably accommodating the barrel. | 02-02-2012 |
20120132059 | WEAPON WITH RECOIL AND BRAKING DEVICE, DAMPING THIS RECOIL - The invention relates to a weapon ( | 05-31-2012 |
Anke Heidbrede, Mannheim DE
Patent application number | Description | Published |
---|---|---|
20090156423 | METHOD AND DEVICE FOR INTEGRATED SYNTHESIS AND ANALYSIS OF ANALYTES ON A SUPPORT - Methods and devices provide integrated synthesis of a support for analyte determination and the analyte determination. Preferred embodiments involve particles immobilized on the surface of a support to which receptors are coupled location-specifically, time-specifically or both on pre-determined positions on the support. | 06-18-2009 |
Anke Heimburg, Magdeburg DE
Patent application number | Description | Published |
---|---|---|
20120028995 | NOVEL COMPOUNDS FOR MEDICAL USE AS PEPTIDASE EFFECTORS - The invention relates to compounds of general formula (I) as set forth in the claims as well as to the use of the compounds of the general formula (1) in the medical field, specifically for use in the suppression of DNA synthesis and inflammatory cytokine production as well as in the stimulation of anti-inflammatory cytokine production in vitro and in vivo. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way. | 02-02-2012 |
Anke Heussr, Hamburg DE
Patent application number | Description | Published |
---|---|---|
20130012544 | PYRAZOLONE DERIVATIVES AS PDE4 INHIBITORS - The compound 1-(2-{4-[3-(3,4-dimethoxyphenyl)-4,4-dimethyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl]piperidin-1-yl}-2-oxoethyl)pyrrolidine-2,5-dione is a novel effective inhibitor of the type 4 phosphodiesterase. | 01-10-2013 |
Anke Homann-Wischinski, Langenfeld DE
Patent application number | Description | Published |
---|---|---|
20110076751 | LYSIS, BINDING AND/OR WASH REAGENT FOR ISOLATING AND/OR PURIFYING NUCLEIC ACIDS - The present invention relates to a lysis, binding and/or wash reagent for isolating and/or purifying nucleic acids and a method for isolating and/or purifying nucleic acids. | 03-31-2011 |
Anke Hoppensack, Stuttgart DE
Patent application number | Description | Published |
---|---|---|
20120301958 | BIOARTIFICIAL PROXIMAL TUBULE SYSTEMS AND METHODS OF USE - This application invention discloses bioartificial proximal tubule device, constructed by preparing a decellularized biological matrix, seeding the biological matrix with mammalian kidney-derived cells and optionally mammalian endothelial cells. The device may then be cultured statically or matured using bioreactor culture to allow differentiation of the kidney cells into functioning proximal tubule cells. The device is capable of carrying out proximal tubule functions. The application also describes various methods of making the proximal tubule devices. The application also further describes methods of use of bioartificial proximal tubule devices for e.g. in vitro studies of tubule cell transport, toxicity effects of various compounds or pharmaceutical compound screening. | 11-29-2012 |
Anke Jaudszus, Mechterstaedt DE
Patent application number | Description | Published |
---|---|---|
20090118369 | Use of CIS-9, Trans-11 Isomer of Conjugated Lineoleic Acid - A composition and medicament comprising the cis-9, trans-11 isomer of conjugated linoleic acid for treating inflammatory diseases, including asthma, is provided. A method for inhibiting the proliferation of human or animal cells of the immune systems involved in an immune response including administering the cis-9, trans-11 isomer of conjugated linoleic acid to a patient is also provided. A nutritional, functional food, or dietary supplement including the cis-9, trans-11 isomer of conjugated linoleic acid is also provided. | 05-07-2009 |
Anke Jedrkowiak, Markgroeningen DE
Patent application number | Description | Published |
---|---|---|
20120059284 | STATUS DETECTING DEVICE TO BE ATTACHED TO A LIVING BEING - A status detecting device is described for being attached to a living being, in particular a person, to detect the position of the body of the living being, having a first sensor, configured as an acceleration sensor and/or a gyroscopic sensor. An additional, second sensor, configured as a height measuring sensor, is also provided. Also described is a corresponding method. | 03-08-2012 |
Anke Jung US
Patent application number | Description | Published |
---|---|---|
20120187593 | PLEATABLE NONWOVEN MATERIAL AND METHOD AND APPARATUS FOR PRODUCTION THEREOF - A pleatable nonwoven material is provided, including thicker form-giving fibers and thinner fibers determining the filter effect, wherein the thinner fibers are incorporated largely homogeneously in the thicker fibers running in the direction along the surface of the nonwoven material and a distribution density gradient of the thinner fibers is established perpendicular to the surface of the nonwoven material such that the highest concentration of thinner fibers is in the region of the center or on one of the two outsides, wherein the thicker and thinner fibers are bonded together by solidification from the melted condition and are made from the same material. | 07-26-2012 |
Anke Jung, Nurnberg DE
Patent application number | Description | Published |
---|---|---|
20130269529 | AIR FILTER MEDIUM COMBINING TWO MECHANISMS OF ACTION - Air filter medium from a non-woven fabric, which is produced in a melt-spinning process and comprises a depth filter component and a surface filter component, the air filter medium being designed such as to have a long service life and the surface filter component allowing regeneration by way of a reverse pulse. | 10-17-2013 |
20150061175 | PLEATABLE NONWOVEN MATERIAL AND METHOD AND APPARATUS FOR PRODUCTION THEREOF - A pleatable nonwoven material is provided, including thicker form-giving fibers and thinner fibers determining the filter effect, wherein the thinner fibers are incorporated largely homogeneously in the thicker fibers running in the direction along the surface of the nonwoven material and a distribution density gradient of the thinner fibers is established perpendicular to the surface of the nonwoven material such that the highest concentration of thinner fibers is in the region of the center or on one of the two outsides, wherein the thicker and thinner fibers are bonded together by solidification from the melted condition and are made from the same material. | 03-05-2015 |
Anke Jung, Bayreuth DE
Patent application number | Description | Published |
---|---|---|
20090117803 | PLEATABLE NONWOVEN MATERIAL AND METHOD AND APPARATUS FOR PRODUCTION THEREOF - A pleatable nonwoven material is provided, including thicker form-giving fibers and thinner fibers determining the filter effect, wherein the thinner fibers are incorporated largely homogeneously in the thicker fibers running in the direction along the surface of the nonwoven material and a distribution density gradient of the thinner fibers is established perpendicular to the surface of the nonwoven material such that the highest concentration of thinner fibers is in the region of the center or on one of the two outsides, wherein the thicker and thinner fibers are bonded together by solidification from the melted condition and are made from the same material. | 05-07-2009 |
Anke Klippel-Giese, Park Ridge, NJ US
Patent application number | Description | Published |
---|---|---|
20110008320 | Further Use of Protein Kinase N Beta - The present invention is related to use of protein kinase N beta or a fragment or derivative thereof as a downstream target of the PI 3-kinase pathway, preferably as a downstream drug target of the PI 3-kinase pathway. | 01-13-2011 |
20120100561 | A PKN3/RHOC MACROMOLECULAR COMPLEX AND METHODS OF USE THEREFOR - Disclosed are compositions comprising and methods of using a novel macromolecular assembly comprising PKN3, PDK1 and RhoC (PPRC complex). The PPRC complex was shown to have kinase activity and was found in cells of high malignancy potential, such as particularly aggressive cancers. In some aspects, the invention provides methods for screening compounds that have cancer therapeutic potential, methods for diagnosing aggressive cancer, methods for determining the prognosis of a patient suffering from cancer, methods for stratifying patients in a clinical trial or determining the effectiveness of a particular treatment regimen, polypeptides that modulate the formation of the PPRC complex, and kits comprising one or more components of the PPRC complex. | 04-26-2012 |
20120171220 | FURTHER USE OF PROTEIN KINASE N BETA - The present invention is related to use of protein kinase N beta or a fragment or derivative thereof as a downstream target of the PI 3-kinase pathway, preferably as a downstream drug target of the PI 3-kinase pathway. | 07-05-2012 |
20130065928 | BIOMARKERS FOR PI3K-DRIVEN CANCER - Disclosed is the discovery that the mTORC2 complex plays a role in the regulation of PKN3 phosphorylation at the turn motif threonine; and the use of the phosphorylation status of the turn motif threonine of PKN3 as a biomarker. In some embodiments, the phosphorylation status of the turn motif threonine of PKN3 is determined using an antibody that specifically binds to the turn motif threonine of a PKN3 protein, such as an anti-phosphoT860 antibody. In some embodiments, the invention relates to methods for screening compounds that have cancer therapeutic potential, methods for diagnosing cancer, methods for determining the prognosis of a patient suffering from cancer, methods for stratifying patients in a clinical trial, methods for treating a patient suffering from cancer, and methods for determining the effectiveness of a particular treatment regimen. | 03-14-2013 |
Anke Klippel-Giese, Berlin DE
Patent application number | Description | Published |
---|---|---|
20090186845 | INTERFERING RNA MOLECULES - The present invention is related to a ribonucleic acid comprising a double stranded structure whereby the double-stranded structure comprises a first strand and a second strand, whereby the first strand comprises a first stretch of contiguous nucleotides and whereby said first stretch is at least partially complementary to a target nucleic acid, and the second strand comprises a second stretch of contiguous nucleotides whereby said second stretch is at least partially identical to a target nucleic acid, and whereby the double stranded structure is blunt ended. | 07-23-2009 |
20100285038 | Factor Involved in Metastasis and Uses Thereof - The present invention is related to a nucleic acid coding for a factor involved in a biological process, whereby the process is a PI 3-kinase pathway regulated process, preferably a process selected from the group comprising glucose metabolism, amino acid and glucose deprivation processes, diabetes, wound healing, stress response, apoptosis, metastasis, tumorigenesis, cell migration, cell motility in extracellular matrix and cell growth in extracellular matrix, and the factor is a polypeptide comprising an amino acid sequence according to SEQ ID. NO. 1 or a polypeptide having a sequence according to databank entries gi 9506687 or NP_061931, preferably NP_061931.1. | 11-11-2010 |
20110118456 | Interfering RNA Molecules - The present invention is related to a ribonucleic acid comprising a double stranded structure whereby the double-stranded structure comprises a first strand and a second strand, whereby the first strand comprises a first stretch of contiguous nucleotides and whereby said first stretch is at least partially complementary to a target nucleic acid, and the second strand comprises a second stretch of contiguous nucleotides whereby said second stretch is at least partially identical to a target nucleic acid, and whereby the double stranded structure is blunt ended. | 05-19-2011 |
20130102769 | INTERFERING RNA MOLECULES - The present invention is related to a ribonucleic acid comprising a double stranded structure whereby the double-stranded structure comprises a first strand and a second strand, whereby the first strand comprises a first stretch of contiguous nucleotides and whereby said first stretch is at least partially complementary to a target nucleic acid, and the second strand comprises a second stretch of contiguous nucleotides whereby said second stretch is at least partially identical to a target nucleic acid, and whereby the double stranded structure is blunt ended. | 04-25-2013 |
Anke Kretz-Rommel, San Deigo, CA US
Patent application number | Description | Published |
---|---|---|
20100105620 | Polypeptides that bind Trail-R1 and Trail-R2 - Agonists for TRAIL death receptors including polypeptides having a multimerizing, e.g. trimerizing, domain and a polypeptide sequence that binds to at least one of TRAIL death receptors TRAIL-R1 and TRAIL-R2. Agonists are described that do not bind to TRAIL decoy receptors. The multimerizing domain may be derived from human tetranectin. The agonists can induce apoptosis in pathogenic cells expressing a TRAIL death receptor. Pharmaceutical compositions are described for treating diseases associated with cells expressing DR4 and DR5, such as tumor cells. Methods for selecting polypeptides and preparing multimeric complexes. | 04-29-2010 |
Anke Küdde, Güntersleben DE
Patent application number | Description | Published |
---|---|---|
20090209701 | WATER-BASED LACQUERS COMPRISING HIGHLY FUNCTIONAL, HIGHLY BRANCHED OR HYPERBRANCHED POLYCARBONATES - The present invention relates to aqueous basecoat materials which comprise high-functionality, highly branched or hyperbranched polycarbonates based on dialkyl or diaryl carbonates or on phosgene, diphosgene or triphosgene and on aliphatic, aliphatic/aromatic or aromatic diols or polyols. | 08-20-2009 |
Anke Küdde, Güntersleben DE
Patent application number | Description | Published |
---|---|---|
20090209701 | WATER-BASED LACQUERS COMPRISING HIGHLY FUNCTIONAL, HIGHLY BRANCHED OR HYPERBRANCHED POLYCARBONATES - The present invention relates to aqueous basecoat materials which comprise high-functionality, highly branched or hyperbranched polycarbonates based on dialkyl or diaryl carbonates or on phosgene, diphosgene or triphosgene and on aliphatic, aliphatic/aromatic or aromatic diols or polyols. | 08-20-2009 |
Anke Küdde, Guentersleben DE
Patent application number | Description | Published |
---|---|---|
20110318495 | AQUEOUS COATING MATERIAL, ITS PREPARATION AND USE - The present invention relates to an aqueous coating material comprising at least one ionically and/or nonionically stabilized polyurethane, which is saturated, unsaturated and/or grafted with olefinically unsaturated compounds, and at least one organic, aliphatic solvent, wherein said solvent has a solubility parameter δ<10 (cal/cm | 12-29-2011 |
Anke Liewald, Frankfurt DE
Patent application number | Description | Published |
---|---|---|
20120268741 | ARRANGEMENT FOR DETERMINING A LONGITUDINAL POSITION OF A STOPPER - The invention refers to an arrangement and a method for determining a longitudinal position of a stopper for sealing a compartment of a translucent medicament container for a liquid medicament (M). The arrangement comprises a circular light source and a photo sensitive sensor, wherein either the light source or the sensor is laterally arrangeable next to the medicament container extending over at least part of the length of the medicament container, and wherein the respective other of the light source and the sensor is arrangeable in a circular manner around a head of the medicament container. The light source is arranged to emit light into the medicament container. The light is scattered by the medicament or medicament container and detected by the sensor. The sensor is connected to a processor unit for detecting the position of the stopper). | 10-25-2012 |
20130131601 | METHOD AND SYSTEM FOR DIFFERENTIATING DRUG DELIVERY DEVICES - A method and system is disclosed for differentiating a drug delivery device that may be used to administer a plurality of drug types. The drug delivery system includes a drug delivery device and a differentiation shell. The drug delivery device holds a given medicament. A differentiation shell is attachable to the drug delivery device. The differentiation shell may include at least one shell-type feature configured to attach to a drug delivery device and at least one differentiation feature. The differentiation feature identifies the given medicament in the drug delivery device. | 05-23-2013 |
Anke Liewald, Frankfurt Am Main DE
Patent application number | Description | Published |
---|---|---|
20120143147 | Bung for Drug Containing Cartridges in Drug Delivery Devices - The present invention relates to a bung ( | 06-07-2012 |
20120195182 | System Comprising a Drug Delivery Device and a Cartridge Provided with a Bung and a Method of Identifying the Cartridge - The present invention relates to a bung ( | 08-02-2012 |
20130012884 | Drug Delivery Device and Associated Packaging - The present invention relates to a drug delivery device and in particular to temperature sensitive labelling of such devices. The Drug delivery device is designed for dispensing of a dose of a medicinal product and comprises a housing ( | 01-10-2013 |
Anke Luedge, Schulzendorf DE
Patent application number | Description | Published |
---|---|---|
20090068407 | METHOD FOR PRODUCING A MONOCRYSTALLINE SI WAFER HAVING AN APPROXIMATELY POLYGONAL CROSS-SECTION AND CORRESPONDING MONOCRYSTALLINE SI WAFER - A method of making a single-crystalline Si wafer with an approximately polygonal cross section and having a material property that is the same as a zone-pulled Si crystal, and the single-crystalline Si wafer. The method includes pulling at least one bottle neck of a crystal vertically downwards from a rotating hanging melt drop. The rotational speed of the crystal is reduced to between 0 and less than 1 rpm. In a crystal-growth phase, a Si single crystal ingot is pulled vertically downwards with an approximately polygonal cross section. An inductor is used to generate a temperature profile at a growth phase boundary of the crystal that corresponds to the shape of a cross section of the pulled Si single crystal ingot. The growth is ended at a desired pulling length and the Si single crystal ingot is cut into wafers having an approximately polygonal cross section. | 03-12-2009 |
Anke Mayer-Bartschmid, Wulfrath DE
Patent application number | Description | Published |
---|---|---|
20110015248 | SUBSTITUTED HETEROCYCLES - The present invention relates to substituted heterocycles, processes for their preparation, and their use in medicaments, especially for the treatment of inflammatory disease, i.e. asthma, or cancer. | 01-20-2011 |
20120321619 | ANTI-C4.4A ANTIBODIES AND USES THEREOF - The present invention provides recombinant antigen-binding regions and antibodies and functional fragments containing such antigen-binding regions that are specific for the membrane-anchored, 29 kDa C4.4a polypeptide, which is over expressed in several tumors, e.g. lung, colorectal, pancreas, prostate, renal and breast cancer. These antibodies, accordingly, can be used to treat these and other disorders and conditions. Antibodies of the invention also can be used in the diagnostics field, as well as for further investigating the role of C4.4a in the progression of disorders associated with cancer. The invention also provides nucleic acid sequences encoding the foregoing antibodies, vectors containing the same, pharmaceutical compositions and kits with instructions for use. | 12-20-2012 |
20140050743 | BINDING PROTEINS TO INHIBITORS OF COAGULATION FACTORS - The present invention relates to the identification and use of antigen-binding regions, antibodies, antigen-binding antibody fragments and antibody mimetics, neutralizing the anti-coagulant effect of an anticoagulant in vitro and/or in vivo. Antibodies and functional fragments of the invention and antibody mimetics can be used to specifically reverse the pharmacological effect of an anticoagulant e.g. a FXa inhibitor for therapeutic (antidote) and/or diagnostic purposes. The invention also provides nucleic acid sequences encoding foregoing molecules, vectors containing the same, pharmaceutical compositions and kits with instructions for use. | 02-20-2014 |
Anke Mayer-Bartschmid, Wuelfrath DE
Patent application number | Description | Published |
---|---|---|
20090252804 | MEDICAL DEVICES WITH AN ANTIBACTERIAL POLYURETHANEUREA COATING - The present invention relates to a medical device which has at least one coating which is obtained starting from an aqueous dispersion, the aqueous dispersion comprising at least one nonionically stabilized polyurethaneurea and at least one silver-containing constituent. | 10-08-2009 |
20090253848 | AQUEOUS SILVER-CONTAINING NONIONIC POLYURETHANE DISPERSIONS - The present invention relates to an aqueous dispersion comprising at least one nonionically stabilized polyurethaneurea and at least one silver-containing constituent. | 10-08-2009 |
Anke Mueller, Germering DE
Patent application number | Description | Published |
---|---|---|
20100184789 | INHIBITORS OF PROTEIN KINASES - The present invention relates to inhibitors of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to methods of preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases comprising the administration of an effective amount of at least one inhibitor of cyclin-dependent kinases. | 07-22-2010 |
20110306602 | 4, 6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES - The present invention relates to inhibitors of general Formula (I) of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to compounds for preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases. | 12-15-2011 |
20130338147 | 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES - The present invention relates to inhibitors of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to methods of preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases comprising the administration of an effective amount of at least one inhibitor of cyclin-dependent kinases. | 12-19-2013 |
Anke Müller, Germering DE
Patent application number | Description | Published |
---|---|---|
20100249149 | Inhibitors of Protein Kinases - are useful as inhibitors of cyclin dependent kinases such as CDK9. | 09-30-2010 |
20150038516 | Inhibitors of Protein Kinases - Compounds of general Formula I: | 02-05-2015 |
Anke Müller, Germering DE
Patent application number | Description | Published |
---|---|---|
20100249149 | Inhibitors of Protein Kinases - are useful as inhibitors of cyclin dependent kinases such as CDK9. | 09-30-2010 |
Anke Pilzner, Hamburg DE
Patent application number | Description | Published |
---|---|---|
20130059929 | MICROBIOLOGICALLY STABLE, EASILY APPLICABLE PREPARATIONS - Cosmetic or dermatological preparations show improved sensory properties and sufficient microbiological stability due to the addition of benzethonium chloride, methylisothiazolinone, piroctone olamine and/or lauroyl ethyl arginate, the cosmetic or dermatological preparations not comprising any other preservatives, and are especially free of parabens and/or phenoxyethanol. | 03-07-2013 |
Anke Rattenholl, Halle DE
Patent application number | Description | Published |
---|---|---|
20100203589 | METHOD FOR OBTAINING ACTIVE BETA-NGF - The invention relates to a method for producing biologically active β-NGF from the proform proNGF. After expressing the proform of the β-NGF in a prokaryotic host cell, the recombinant protein is isolated in the form of insoluble inactive aggregates (inclusion bodies). After the solubilization thereof in a strong denaturing agent and the subsequent conversion thereof into the natural conformation, which is determined by the disulfide bridges present in the natural β-NGF, biologically active β-NGF is obtained by subsequently splitting-off the prosequence. | 08-12-2010 |
Anke Reinschmidt, Essen DE
Patent application number | Description | Published |
---|---|---|
20130174760 | DEFOAMER COMPOSITIONS FOR BUILDING-PRODUCT MIXTURES - The present application relates to compositions comprising at least one siloxane and at least one superplasticizer based on polycarboxylate ethers or sulphonates of lignin, melamine or naphthalene or of resins thereof, and to the use of such compositions as or in building-product mixtures or building products, especially mortar mixtures or concrete mixtures. | 07-11-2013 |
Anke Reinschmidt, Macungie, PA US
Patent application number | Description | Published |
---|---|---|
20120077906 | Flexible Watertight Roof Coatings - The invention provides for the use of coating compositions based on one or more mineral binders, one or more polymers, one or more fillers, and, if desired, one or more additives for producing roof coatings, the coating compositions comprising at least 50% by weight of polymers, based on the dry weight of the polymers and of the mineral binders. | 03-29-2012 |
Anke Richter, Munchen DE
Patent application number | Description | Published |
---|---|---|
20080276198 | Method for Controlling a Device - A device with a graphical user interface, via which the functions of the device are controlled has functions divided into categories which are sub-divided into subcategories. The categories are represented by primary regions that are schematically arranged on the user interface. The primary regions contain elements, each of which represents a sub-category of the category of the respective primary region. In addition, only one primary region is expanded by the display of a secondary region after an element has been selected. The secondary region contains control elements for at least one function that is assigned to the sub-category representing the selected element. The at least one function is controlled by the control elements. | 11-06-2008 |
Anke Robeller, Boeblingen DE
Patent application number | Description | Published |
---|---|---|
20090178041 | Method for Counting Events - The invention relates to a method for counting events in an information technology system which performs one or more threads of executions, wherein an event counter is introduced comprising: | 07-09-2009 |
Anke Stuken, Oslo NO
Patent application number | Description | Published |
---|---|---|
20140113301 | DETECTION OF SAXITOXIN-PRODUCING DINOFLAGELLATES - The current disclosure generally relates to the field of saxitoxins and the identification of microorganisms capable of producing them. In particular, the saxitoxin A (sxtA) gene comprising catalytic domain sequences saxitoxin A1 (sxtA1) and saxitoxin A4 (sxtA4) is identified in a number of dinoflagellate species. The disclosure relates to methods of detection of saxitoxin-producing dinoflagellates by amplification and detection of the sxtA gene (in particular by PCR) and kits and primers for use in the method are also disclosed. Saxitoxin-producing dinoflagellate genera detected by the method include | 04-24-2014 |
Anke Traebert, Stuttgart DE
Patent application number | Description | Published |
---|---|---|
20110005199 | Method for Reducing Emission of Nitrogen Oxide in a Motor Vehicle Having a Lean Burning Internal Combustion Engine - In a method for reducing the emission of nitrogen dioxide in a motor vehicle having an exhaust gas purification system having an SCR catalytic converter with adsorption centers for nitrogen oxides, an exhaust gas enriched with ammonia is supplied to the SCR catalytic converter above an operating temperature. Below the operating temperature, the exhaust gas supplied to the SCR catalytic converter is enriched with a material such that an adsorption of nitrogen oxides is inhibited at corresponding adsorption centers of the SCR catalytic converter. In order to reduce the overall NO | 01-13-2011 |
20120004825 | Method for the Operation of an Internal Combustion Engine Comprising an Emission Control System that Includes an SCR Catalyst - A method for operating an internal combustion engine comprising an exhaust gas cleaning system that includes a SCR catalyst. In conjunction with a cold start and/or a warm-up of the internal combustion engine, the internal combustion engine is operated using a cold start engine operation method having predefineable values for predefineable operating parameters of the internal combustion engine. An amount of nitrogen oxides stored in the SCR catalyst is estimated, and the cold start engine operation method is activated when the estimation indicates that the nitrogen oxide storage amount exceeds a predefineable nitrogen oxide storage amount limit value. | 01-05-2012 |
20120004833 | Method for Operating an Internal Combustion Engine with an Emission Control System - A method for operating an internal combustion engine comprising an emission control system that includes at least one catalytic and/or filter-effective emission control component. In conjunction with a cold start and/or a warm-up of the internal combustion engine, the internal combustion engine is operated using a cold start engine operation process having predefined values for predefined operating parameters of the internal combustion engine. An amount of hydrocarbons (HC) stored in one or more of the at least one emission control component is estimated, and the cold start engine operation process is activated when the estimation indicates that the amount of stored HC exceeds a predefined maximum amount of stored HC. | 01-05-2012 |
Anke Tusche, Rietschen DE
Patent application number | Description | Published |
---|---|---|
20110318818 | STRAW FOR THE CONSERVATION OF A PREDETERMINED DOSE OF A LIQUID BASE SUBSTANCE, IN PARTICULAR A BIOLOGICAL SUBSTANCE - The straw comprises a tube ( | 12-29-2011 |
Anke Vietgen-Zeidler, Brunegg CH
Patent application number | Description | Published |
---|---|---|
20120168244 | INDUSTRIAL PLANT WITH NOISE ATTENUATION HOOD - A noise-emitting industrial plant is provided, which is enclosed by a personnel-accessible noise attenuation hood for damping noise which issues from the plant. The noise attenuation hood includes a horizontal working platform which is provided for maintenance operations and/or repair work. The working platform is arranged at the noise attenuation hood in a foldout manner. | 07-05-2012 |
Anke Vogelgsang, Goettingen DE
Patent application number | Description | Published |
---|---|---|
20080247050 | MICROSCOPE OBJECTIVE - The invention relates to a microscope objective which consists of at least four lenses or groups of lenses and can preferably be used to improve image contrast. | 10-09-2008 |
Anke Wagner, Salem DE
Patent application number | Description | Published |
---|---|---|
20130199555 | APPLICATOR DEVICE FOR APPLYING AT LEAST ONE APPLICATION AGENT TO FIBROUS MATERIALS - The invention relates to an applicator device for applying at least one application agent ( | 08-08-2013 |
20130206158 | APPLICATOR DEVICE FOR APPLYING AN APPLICATION AGENT TO HAIR - The invention starts out from an applicator for applying at least one application medium ( | 08-15-2013 |
20130255708 | DEVICE, SYSTEM AND METHOD FOR APPLYING AT LEAST ONE APPLICATION AGENT TO HAIR - The invention relates to a device for applying at least one application agent to hair, comprising a housing unit ( | 10-03-2013 |
20140251363 | APPLICATION DEVICE - An application device applies an active agent to a fibrous material. The application device has a housing defining a storage volume which is arranged in the housing and is intended for storing the active agent, and an applicator. By the applicator, the active agent located in an application volume is applied to the material. In order to make reliable and straightforward application possible, the applicator has an application volume, a number of hollow teeth which are arranged in a comb-like manner and have an upper wall and a lower wall, between which at least part of the application volume is arranged, and also gaps which are located between the teeth and are intended for introducing the material into the application volume. | 09-11-2014 |
Anke Wendschlag, Mannheim DE
Patent application number | Description | Published |
---|---|---|
20140193822 | COMPLEX SETS OF MIRNAS AS NON-INVASIVE BIOMARKERS FOR KIDNEY CANCER - The present invention relates to non-invasive methods, kits and means for diagnosing and/or prognosing of kidney cancer in a body fluid sample from a subject. Further, the present invention relates to set of polynucleotides or sets of primer pairs for detecting sets of miRNAs for diagnosing and/or prognosing of kidney cancer in a body fluid sample from a subject. In addition, the present invention relates to sets of miRNAs for diagnosing and/or prognosing of kidney cancer in a body fluid sample from a subject. | 07-10-2014 |
20140213476 | COMPLEX SETS OF MIRNAS AS NON-INVASIVE BIOMARKERS FOR COLON CANCER - The present invention relates to non-invasive methods, kits and means for diagnosing and/or prognosing of colon cancer in a body fluid sample from a subject. Further, the present invention relates to set of polynucleotides or sets of primer pairs for detecting sets of miRNAs for diagnosing and/or prognosing of colon cancer in a body fluid sample from a subject. In addition, the present invention relates to sets of miRNAs for diagnosing and/or prognosing of colon cancer in a body fluid sample from a subject. | 07-31-2014 |
20150037327 | miRNA based treatment monitoring in multiple sclerosis - The present invention relates to methods of determining whether a patient responds to a therapeutic treatment of multiple sclerosis (MS), of monitoring the course of multiple sclerosis (MS) in a patient, of determining the risk for a relapse of multiple sclerosis (MS) in a patient, and of adjusting the dose of a therapeutic drug applied for therapeutic treatment of multiple sclerosis in a patient. Said methods are based on the determination of the level of at least one miRNA in a test sample isolated from the patient. The present invention also relates to a method of identifying a compound suitable for the treatment of multiple sclerosis in a patient. Further, the present invention relates to the use of a polynucleotide or a polynucleotide set for detecting a miRNA to determine whether a patient responds to a therapeutic treatment of multiple sclerosis, to monitor the course of multiple sclerosis in a patient, to determine the risk of a relapse of multiple sclerosis in a patient, to adjust the dose of a therapeutic drug applied for therapeutic treatment of multiple sclerosis in a patient, and to identify a compound suitable for the treatment of multiple sclerosis in a patient. Furthermore, the present invention relates to a kit for determining whether a patient responds to a therapeutic treatment of multiple sclerosis, for monitoring the course of multiple sclerosis in a patient, for determining the risk of a relapse of multiple sclerosis in a patient, for adjusting the dose of a therapeutic drug applied for therapeutic treatment of multiple sclerosis in a patient, or for identifying a compound suitable for the treatment of multiple sclerosis in a patient comprising means for determining the level of at least one miRNA in a test sample isolated from a patient. | 02-05-2015 |
Anke Woestemeyer, Jena DE
Patent application number | Description | Published |
---|---|---|
20080207461 | Devices for Conducting and Analyzing Microarray Experiments - The present invention relates to devices for the simultaneous performance of microarray experiments for detecting specific interactions between probe and target molecules in a microtiter plate as well as to methods for manufacturing such devices. Furthermore, the present invention relates to the use of such devices in a method for qualitatively and/or quantitatively detecting specific interactions between probe and target molecules. | 08-28-2008 |
Anke Wolf, Rio De Janeiro BR
Patent application number | Description | Published |
---|---|---|
20100263357 | THREE WAY CATALYST - A double-layer three-way catalyst for purification of the exhaust gases from internal combustion engines which has excellent activity and thermal stability is described. The catalyst contains active aluminium oxide and a first cerium/zirconium mixed oxide which are both catalytically activated with palladium in the first layer applied to a catalyst support. In the second layer which is in direct contact with the exhaust gas, the catalyst likewise contains an active aluminium oxide and a second cerium/zirconium mixed oxide which are both catalytically activated with rhodium. The second cerium/zirconium mixed oxide has a higher zirconium oxide content than the first mixed oxide. | 10-21-2010 |
Anke Wostemeyer, Jena DE
Patent application number | Description | Published |
---|---|---|
20120058464 | Assay Methods Using Array of Test Zones - A method for assaying a sample for each of multiple analytes is described. The method includes contacting an array of spaced-apart test zones with a liquid sample (e.g., whole blood). The test zones disposed within a channel of a microfluidic device. The channel is defined by at least one flexible wall and a second wall which may or may not be flexible. Each test zone comprising a probe compound specific for a respective target analyte. The microfluidic device is compressed to reduce the thickness of the channel, which is the distance between the inner surfaces of the walls within the channel. The presence of each analyte is determined by optically detecting an interaction at each of multiple test zones for which the distance between the inner surfaces at the corresponding location is reduced. The interaction at each test zone is indicative of the presence in the sample of a target analyte. Capillary structures of the devices or used in the methods may comprise a matrix and the devices may comprise control elements and methods for assaying of sample may use corresponding controlling activities. | 03-08-2012 |
Anke Wöstemeyer, Jena DE
Patent application number | Description | Published |
---|---|---|
20110124114 | Assays - A method for assaying a sample for each of multiple analytes is described. The method includes contacting an array of spaced-apart test zones with a liquid sample (e.g., whole blood). The test zones disposed within a channel of a microfluidic device. The channel is defined by at least one flexible wall and a second wall which may or may not be flexible. Each test zone comprising a probe compound specific for a respective target analyte. The microfluidic device is compressed to reduce the thickness of the channel, which is the distance between the inner surfaces of the walls within the channel. The presence of each analyte is determined by optically detecting an interaction at each of multiple test zones for which the distance between the inner surfaces at the corresponding location is reduced. The interaction at each test zone is indicative of the presence in the sample of a target analyte. Capillary structures of the devices or used in the methods may comprise a matrix and the devices may comprise control elements and methods for assaying of sample may use corresponding controlling activities. | 05-26-2011 |
Anke Zobywalski, Griesheim DE
Patent application number | Description | Published |
---|---|---|
20100284976 | COMPOSITIONS FOR THE PREPARATION OF MATURE DENDRITIC CELLS - The invention relates to a method for in vitro maturation of at least one immature dendritic cell, comprising stimulating said immature dendritic cell with TNFα, IL-1β, IFNγ, a TLR7/8 agonist and prostaglandin E2 (PG). Furthermore, the invention relates to a composition comprising said factors as well as to mature dendritic cells produced by the method of the invention. | 11-11-2010 |
20140302096 | COMPOSITIONS FOR THE PREPARATION OF MATURE DENDRITIC CELLS - The invention relates to a method for in vitro maturation of at least one immate dendritic cell, comprising stimulating said immature dendritic cell with TNFα, IL-1β, IFNγ, a TLR7/8 agonist and prostaglandin E2(PG). Furthermore, the invention elates to a composition comprising these factors as well as to mature dendritic cells produced by a method of the invention. | 10-09-2014 |